A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.
A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.
This is a long-term safety follow-up study to assess the post-treatment safety, at 12 and 24 months, in patients with type 2 diabetes after participation in the phaseII/III studies GALLANT, GALLEX and ARMOR. In addition, selected patients, including those with pre-defined laboratory or clinical findings, will have a 12-week post-treatment follow-up visit, including laboratory evaluation and adverse event recording.
Inclusion Criteria:
Exclusion Criteria:
Searcy, Arizona, United States
Roseland, Texas, United States
Ciudad de Buenos Aires, Argentina
Tasmania, Australia
Windzor, Nova Scotia, Canada
North York, Ontario, Canada
Saint Catherines, Ontario, Canada
Smith Falls, Ontario, Canada
Ambriere Les Vallees, France
Fontaine Saint Martin, France
Lambersat, France
Mars Da Tour, France
Nürberg, Germany
Rotenburg/Fulda, Germany
Gy?r, Hungary
Monteccio Emilia, Italy
Kubang Kerian, Kota Bharu, Malaysia
Guadalajara, Jalisco, Mexico
Nuevo León, Monterrey, Mexico
Veracruz, Veracruz, Mexico
Zapopan , Jalisco, Mexico
Enebakk, Norway
Inderøy, Norway
Soerumsand, Norway
Katowice - Ochojec, Poland
P³ock, Poland
Toruñ, Poland
Belgrade, Serbia and Montenegro
Gauteng, South Africa
Houghton Gauteng, South Africa
San Vicente de Raspeig (Alicante), Spain
Skrivarp, Sweden
Berks, United Kingdom
Bucks, United Kingdom
Co Antrim N Ireland, United Kingdom
Pembrokeshire, United Kingdom
Surrey, United Kingdom
West Midlands, United Kingdom
Wiltshire, United Kingdom